Literature DB >> 19551831

Correlation of rhinovirus load in the respiratory tract and clinical symptoms in hospitalized immunocompetent and immunocompromised patients.

G Gerna1, A Piralla, F Rovida, V Rognoni, A Marchi, F Locatelli, F Meloni.   

Abstract

While human rhinoviruses (HRVs) are well accepted as a major cause of common cold syndromes (rhinitis), their role in the etiology of lower respiratory tract infections is still controversial, and their detection in asymptomatic patients is relatively common. The HRV pathogenic role in four groups of hospitalized patients (pediatric immunocompetent and immunocompromised patients, and adult immunocompetent and immunocompromised patients) was investigated by quantifying HRV load in nasopharyngeal aspirates or bronchoalveolar lavage samples by real-time reverse transcription PCR (RT-PCR). Real-time RT-PCR was performed in duplicate on all respiratory samples resulting positive by qualitative RT-PCR. In addition, molecular typing allowed detection of all known HRV species (A, B, and C). In immunocompetent pediatric patients HRVs were mostly associated with lower respiratory tract infections (in the absence of other viral agents) and wheezing, when viral load was > or =10(6) RNA copies/ml. In young immunocompromised patients (stem cell transplantation recipients), an inverse correlation between HRV persistence over time and time at which the infection occurred after transplantation was observed, whereas in adult immunocompromised patients (lung transplant recipients) HRVs could be detected at a medium-low level (<10(5) RNA copies/ml) in bronchoalveolar lavage samples taken routinely from asymptomatic patients. In conclusion, when detected at high viral load, HRVs may cause severe upper and lower respiratory tract infections, whereas when detected at a medium-low viral load, an event more frequent in immunocompromised subjects, they may represent only bystander viruses. 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19551831      PMCID: PMC7159321          DOI: 10.1002/jmv.21548

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  51 in total

1.  Early detection of acute rhinovirus infections by a rapid reverse transcription-PCR assay.

Authors:  C Steininger; S W Aberle; T Popow-Kraupp
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

2.  Rhinovirus infections in myelosuppressed adult blood and marrow transplant recipients.

Authors:  S Ghosh; R Champlin; R Couch; J Englund; I Raad; S Malik; M Luna; E Whimbey
Journal:  Clin Infect Dis       Date:  1999-09       Impact factor: 9.079

3.  A comparison of nested polymerase chain reaction and immunofluorescence for the diagnosis of respiratory infections in children with bronchiolitis, and the implications for a cohorting strategy.

Authors:  G M Ong; D E Wyatt; H J O'Neill; C McCaughey; P V Coyle
Journal:  J Hosp Infect       Date:  2001-10       Impact factor: 3.926

4.  Viral pneumonia in the first month of life.

Authors:  M J Abzug; A C Beam; E A Gyorkos; M J Levin
Journal:  Pediatr Infect Dis J       Date:  1990-12       Impact factor: 2.129

5.  Rhinovirus replication causes RANTES production in primary bronchial epithelial cells.

Authors:  M K Schroth; E Grimm; P Frindt; D M Galagan; S I Konno; R Love; J E Gern
Journal:  Am J Respir Cell Mol Biol       Date:  1999-06       Impact factor: 6.914

6.  Frequency and natural history of rhinovirus infections in adults during autumn.

Authors:  E Arruda; A Pitkäranta; T J Witek; C A Doyle; F G Hayden
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

7.  Asthma exacerbations in children associated with rhinovirus but not human metapneumovirus infection.

Authors:  William D Rawlinson; Zubair Waliuzzaman; Ian W Carter; Yvonne C Belessis; Katarnya M Gilbert; John R Morton
Journal:  J Infect Dis       Date:  2003-03-26       Impact factor: 5.226

8.  Picornavirus infections in children diagnosed by RT-PCR during longitudinal surveillance with weekly sampling: Association with symptomatic illness and effect of season.

Authors:  Birgit Winther; Frederick G Hayden; J Owen Hendley
Journal:  J Med Virol       Date:  2006-05       Impact factor: 2.327

9.  A novel pancoronavirus RT-PCR assay: frequent detection of human coronavirus NL63 in children hospitalized with respiratory tract infections in Belgium.

Authors:  Elien Moës; Leen Vijgen; Els Keyaerts; Kalina Zlateva; Sandra Li; Piet Maes; Krzysztof Pyrc; Ben Berkhout; Lia van der Hoek; Marc Van Ranst
Journal:  BMC Infect Dis       Date:  2005-02-01       Impact factor: 3.090

10.  Predominance of rhinovirus in the nose of symptomatic and asymptomatic infants.

Authors:  Inesz van Benten; Laurens Koopman; Bert Niesters; Wim Hop; Barbara van Middelkoop; Leon de Waal; Kees van Drunen; Albert Osterhaus; Herman Neijens; Wytske Fokkens
Journal:  Pediatr Allergy Immunol       Date:  2003-10       Impact factor: 6.377

View more
  58 in total

Review 1.  Spectrum of viral infections in patients with cystic fibrosis.

Authors:  H Frickmann; S Jungblut; T O Hirche; U Groß; M Kuhns; A E Zautner
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-09-10

2.  Lower airway rhinovirus burden and the seasonal risk of asthma exacerbation.

Authors:  Loren C Denlinger; Ron L Sorkness; Wai-Ming Lee; Michael D Evans; Michele J Wolff; Sameer K Mathur; Gina M Crisafi; Katie L Gaworski; Tressa E Pappas; Rose F Vrtis; Elizabeth A Kelly; James E Gern; Nizar N Jarjour
Journal:  Am J Respir Crit Care Med       Date:  2011-11-01       Impact factor: 21.405

3.  Rhinovirus Disease in Children Seeking Care in a Tertiary Pediatric Emergency Department.

Authors:  Helen Y Chu; Janet A Englund; Bonnie Strelitz; Kirsten Lacombe; Charla Jones; Kristin Follmer; Emily K Martin; Miranda Bradford; Xuan Qin; Jane Kuypers; Eileen J Klein
Journal:  J Pediatric Infect Dis Soc       Date:  2014-10-19       Impact factor: 3.164

4.  Comparison of two multiplex methods for detection of respiratory viruses: FilmArray RP and xTAG RVP.

Authors:  Kenneth H Rand; Howard Rampersaud; Herbert J Houck
Journal:  J Clin Microbiol       Date:  2011-04-20       Impact factor: 5.948

Review 5.  Respiratory viral infections in hematopoietic stem cell and solid organ transplant recipients.

Authors:  S Samuel Weigt; Aric L Gregson; Jane C Deng; Joseph P Lynch; John A Belperio
Journal:  Semin Respir Crit Care Med       Date:  2011-08-19       Impact factor: 3.119

6.  Effects of rhinovirus species on viral replication and cytokine production.

Authors:  Kazuyuki Nakagome; Yury A Bochkov; Shamaila Ashraf; Rebecca A Brockman-Schneider; Michael D Evans; Thomas R Pasic; James E Gern
Journal:  J Allergy Clin Immunol       Date:  2014-03-14       Impact factor: 10.793

7.  Prospective multicenter study of viral etiology and hospital length of stay in children with severe bronchiolitis.

Authors:  Jonathan M Mansbach; Pedro A Piedra; Stephen J Teach; Ashley F Sullivan; Tate Forgey; Sunday Clark; Janice A Espinola; Carlos A Camargo
Journal:  Arch Pediatr Adolesc Med       Date:  2012-08

8.  Rhinovirus C15 Induces Airway Hyperresponsiveness via Calcium Mobilization in Airway Smooth Muscle.

Authors:  Vishal Parikh; Jacqueline Scala; Riva Patel; Corinne Corbi; Dennis Lo; Yury A Bochkov; Joshua L Kennedy; Richard C Kurten; Stephen B Liggett; James E Gern; Cynthia J Koziol-White
Journal:  Am J Respir Cell Mol Biol       Date:  2020-03       Impact factor: 6.914

9.  Graft Loss and CLAD-Onset Is Hastened by Viral Pneumonia After Lung Transplantation.

Authors:  Paul R Allyn; Erin L Duffy; Romney M Humphries; Patil Injean; S Samuel Weigt; Rajan Saggar; Michael Y Shino; Joseph P Lynch; Abbas Ardehali; Bernard Kubak; Chi-Hong Tseng; John A Belperio; David J Ross; Aric L Gregson
Journal:  Transplantation       Date:  2016-11       Impact factor: 4.939

10.  Genetics, recombination and clinical features of human rhinovirus species C (HRV-C) infections; interactions of HRV-C with other respiratory viruses.

Authors:  Anne Wisdom; Aldona E Kutkowska; E Carol McWilliam Leitch; Eleanor Gaunt; Kate Templeton; Heli Harvala; Peter Simmonds
Journal:  PLoS One       Date:  2009-12-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.